Brief: Cancer Genetics And Stemonix Sign Definitive Agreement To Merge

Vyant Bio

24/08/2020 13:25

Aug 24 (Reuters) - Cancer Genetics Inc  CGIX.O :
    * CANCER GENETICS AND STEMONIX SIGN DEFINITIVE AGREEMENT TO
MERGE
    * CANCER GENETICS INC - STEMONIX WILL MERGE WITH A NEWLY
FORMED
SUBSIDIARY OF CANCER GENETICS IN AN ALL-EQUITY TRANSACTION
    * CANCER GENETICS - TO ACQUIRE ALL OF OUTSTANDING CAPITAL
STOCK OF
STEMONIX FOR ABOUT 78% OF OUTSTANDING COMMON STOCK OF CANCER
GENETICS
    * CANCER GENETICS INC - STEMONIX WILL RETAIN ITS NAME
    * CANCER GENETICS INC - COMBINED COMPANY EXPECTS TO REMAIN
LISTED
ON NASDAQ STOCK MARKET

Source text for Eikon:  ID:nGNX9kL2Ph 
Further company coverage:  CGIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))